ELI LILLY & Co is 174.2x more valuable than Centessa Pharmaceuticals plc by market capitalization ($1.070 T vs $6.14 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CNTA | LLY |
|---|---|---|
| Market cap | $6.14 B | $1.070 T |
| US-listed rank | #1252 | #10 |
| Revenue (latest FY) | $15.00M | $65.18B |
| Net income (latest FY) | -$197.53M | $20.64B |
| Net margin | -1316.9% | 31.7% |
| P/E (trailing FY) | - | 51.8 |
| SEC filings | 579 | 989 |
ELI LILLY & Co is 174.2x more valuable than Centessa Pharmaceuticals plc by market capitalization ($1.070 T vs $6.14 B).
In their latest fiscal years, Centessa Pharmaceuticals plc reported $15.00M in revenue while ELI LILLY & Co reported $65.18B.
Full pages: Centessa Pharmaceuticals plc and ELI LILLY & Co, or browse the full rankings.